Movement Disorders

Movement Disorders is the monthly peer-reviewed journal of the International Parkinson and Movement Disorder Society, published by Wiley and established in 1986, covering the clinical and basic science of the field, with a 2025 Journal Impact Factor of 7.7 and a rank of 18th among 296 clinical neurology journals《运动障碍》（Movement Disorders）是（International Parkinson and Movement Disorder Society）的官方月刊，由（Wiley）出版，1986 年创刊，覆盖该领域的临床与基础研究，2025 年影响因子为 7.7，在 296 种临床神经学期刊中列第 18 位。

Scope

• The journal covers the diagnosis and natural history of Parkinson disease and parkinsonism, including the distinction between idiopathic and atypical syndromes该刊覆盖帕金森病与帕金森综合征的诊断和自然史，包括特发性与非典型综合征的鉴别。
• Hyperkinetic disorders form a second core area, spanning dystonia, chorea, tremor, myoclonus, tics and the rarer dyskinesias运动增多性障碍构成第二个核心方向，涵盖肌张力障碍、舞蹈症、震颤、肌阵挛、抽动及较少见的运动障碍。
• Genetics and molecular pathogenesis are central, from monogenic forms of parkinsonism to the pathways underlying neurodegeneration遗传学与分子发病机制居核心位置，从单基因型帕金森综合征到神经退行性变的通路机制。
• Neuroimaging and fluid biomarkers are published with increasing weight, reflecting the shift toward biologically defined disease stages神经影像与体液生物标志物的比重不断上升，反映学界向生物学分期转变的趋势。
• Therapeutics are covered across the pipeline, including pharmacological trials, device-aided therapies such as deep brain stimulation and infusion therapies, and rehabilitation治疗学贯穿全程，包括药物试验、脑深部电刺激与输注治疗等器械辅助疗法以及康复。
• Physiology, biochemistry, pharmacology, epidemiology and animal models of movement disorders complete the scope, together with historical reports on the development of the field运动障碍的生理学、生物化学、药理学、流行病学与动物模型构成本刊其余范围，并收录该领域发展史的历史报告。

History

• The journal was established in 1986 as the official publication of the Movement Disorder Society, giving the emerging subspecialty its first dedicated clinical journal该刊于 1986 年创刊，作为（Movement Disorder Society）的官方出版物，使这一新兴亚专科首次拥有专属临床期刊。
• It has been published by Wiley throughout its life and appears monthly, with supplements accompanying some volumes该刊长期由（Wiley）出版，按月发行，部分卷次附有增刊。
• The society now also publishes Movement Disorders Clinical Practice, a companion title launched in 2014 for clinical and case-based material该学会另出版姊妹刊《运动障碍临床实践》（Movement Disorders Clinical Practice），2014 年创刊，侧重临床与病例类内容。
• For 2026 the journal is running a 40th anniversary collection of scientific perspectives that revisit the most influential work of its first four decades2026 年该刊推出四十周年专题系列，以科学展望的形式回顾创刊四十年来最具影响力的研究。
• Publishing is hybrid, with subscription access as the default and an open access option for accepted articles该刊采用混合出版模式，以订阅访问为默认方式，作者可为录用稿件选择开放获取。
• Its impact factor stood at 10.338 in 2021, 9.698 in 2022, 7.6 in 2024 and 7.7 in 2025该刊影响因子 2021 年为 10.338，2022 年为 9.698，2024 年为 7.6，2025 年为 7.7。

Editors

• The editor-in-chief is A. Jon Stoessl of the University of British Columbia in Vancouver, Canada, a neurologist known for imaging studies of the dopaminergic system in Parkinson disease现任主编为加拿大温哥华（University of British Columbia）的（A. Jon Stoessl），他是以帕金森病多巴胺能系统影像研究著称的神经病学家。
• Two deputy editors support him, Christine Klein of Lubeck in Germany and David G. Standaert of Birmingham, Alabama, in the United States两位副主编协助其工作，即德国吕贝克的（Christine Klein）与美国阿拉巴马州伯明翰的（David G. Standaert）。
• About eighteen associate editors cover subspecialties from genetics and imaging to device therapy, drawn from North America, Europe, Asia and Australia约 18 位副编辑覆盖从遗传学、影像学到器械治疗的各个亚专科，来自北美、欧洲、亚洲与澳大利亚。
• Standing sections have their own editors, including Dimitri Krainc for scientific perspectives and Roberto Erro with Alfonso Fasano for the Gaps and Controversies format常设栏目各有专任编辑，例如（Dimitri Krainc）主持科学展望，（Roberto Erro）与（Alfonso Fasano）主持「空白与争议」栏目。
• A statistical editor and a continuing medical education editor are also appointed, reflecting the journal's emphasis on methods and clinician training该刊另设统计编辑与继续医学教育编辑，体现其对方法学与临床医师培训的重视。
• The editorial team organises a regular journal symposium and handles submissions through the publisher's online system编辑部定期举办期刊研讨会，并通过出版方的在线系统处理投稿。